InvestorsHub Logo
icon url

dirkv

12/05/22 10:12 AM

#4911331 RE: dirkv #4911294

APRE: 0,544 +13,36%
Volume :133.317

Time for a strong rebound??

H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Aprea Therapeutics (APRE - Research Report) and set a price target of $3.00.